Clinical Trial Update: Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating neoadjuvant chemotherapy for non-small cell lung cancer in stages IB, IIA, IIB, and IIIA/T3 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: TERMINATED